A phase I/II study of SB-FIX for the treatment of haemophilia B.

Trial Profile

A phase I/II study of SB-FIX for the treatment of haemophilia B.

Planning
Phase of Trial: Phase I/II

Latest Information Update: 06 Mar 2017

At a glance

  • Drugs SB FIX (Primary)
  • Indications Haemophilia B
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 06 Mar 2017 New trial record
    • 11 Jan 2017 According to the Sangamo Therapeutics media release, company plans to initiate the trial in 2017 and data is expected in late 2017 or early 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top